July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
Outcomes
Abundance of ColidextribacterAbundance of DesulfobacterotaAbundance of Haemophilus+12 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the Fos Biomedical non-transdermal patch system's effects on cardio-metabolic health and sleep quality, finding no significant improvements in key outcomes.
Interventions
Fos Biomedical Non-transdermal Patch System
Outcomes
C-reactive proteinChange in body composition after 12 weeks of treatmentEndothelial function+4 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the efficacy and safety of generic semaglutide compared to innovator semaglutide in Indian adults with type 2 diabetes inadequately controlled on metformin, finding non-inferior results.
Outcomes
Adverse events incidenceBody weightFasting Plasma Glucose (FPG)+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
Interventions
Glargine U100GlimepirideLiraglutide+1 more
Outcomes
Hypoglycemic symptomsSevere hypoglycemia
Added to Dediabetes Jul 12, 2026RCTs
Semaglutide and dulaglutide administered weekly to adults with type 2 diabetes and obesity.
Interventions
DulaglutideMetforminSemaglutide
Outcomes
BMIEpicardial adipose tissue thicknessHbA1c
Added to Dediabetes Jul 12, 2026RCTs
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
Interventions
Glutamine with Sitagliptin
Outcomes
AlbuminuriaBlood urea nitrogen (BUN)Body weight+8 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of green tea extract on glycemic and lipid profiles in patients with type 2 diabetes, finding significant improvements in several metabolic markers.
Interventions
Green tea extract
Outcomes
AdiponectinApolipoprotein A1Apolipoprotein B100+5 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the Greenhabit mobile app for enhancing self-management in type 2 diabetes. Results showed significant improvements in several health metrics compared to standard care.
Interventions
Mobile app for diabetes self-management
Outcomes
BMIBody weightDiabetes social support+9 more
Added to Dediabetes Jul 12, 2026RCTs
This study investigated the effects of GLP-1 receptor agonists, liraglutide and semaglutide, on cardiovascular outcomes in diabetes, finding significant reductions in major adverse cardiovascular events.
Interventions
LiraglutideSemaglutide
Outcomes
Cardiovascular deathComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Incidence of myocardial infarction+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated two health education apps for diabetes management, finding varying levels of user satisfaction and knowledge improvement.
Interventions
Glow app for type 2 diabetes educationMobile app for diabetes self-management
Outcomes
Diabetes knowledgeParticipants' satisfaction evaluation of the APPPatient-reported foot care improvement at 6 months
